| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |